RecruitingNCT05388682

Treatment of Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement

Observation of Long Term Effect of Medical and PTPA Treatment on Patients With Takayasu Arteritis Complicated With Pulmonary Artery Involvement

Sponsor

Chinese Pulmonary Vascular Disease Research Group

Enrollment

200 participants

Start Date

Jan 19, 2014

Study Type

OBSERVATIONAL

Conditions

Takayasu Arteritis With Pulmonary Artery Involvement Percutaneous Transluminal Pulmonary Angioplasty PAH Targeted Medication

Summary

1. Evaluate the effect of medical treatment and percutaneous transluminal pulmonary angioplasty on takayasu arteritis with pulmonary artery involvement 2. evaluate the efficacy of FAPI in predicting the activity and treatment efficacy of takayasu arteritis with pulmonary artery involvement

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Percutaneous transluminal pulmonary angioplasty for people with pah targeted medication, percutaneous transluminal pulmonary angioplasty, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEPercutaneous transluminal pulmonary angioplasty

Percutaneous transluminal pulmonary angioplasty

Locations(1)

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

Beijing, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05388682

Related Trials

Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement

NCT071848141 location